Indolent non-hodgkin lymphoma and T-cell lymphoproliferative disease clinical trials

Clinical trials for patients with Indolent non-Hodgkin Lymphoma or T-cell Lymphoproliferative Disease. These blood disorders affect two types of white blood cells that play an important role in the immune system

If you would like to be considered for a clinical trial you will require a referral from your current treating team. Visit the Joining a Clinical Trial page for referral information. 

For more information on indolent non-hodgkin lymphoma and T-cell lymphoproliferative disease clinical trials, get in contact with our Haem C team This email address is being protected from spambots. You need JavaScript enabled to view it.

Open and Recruiting Clinical Trials

If you don’t find what you are looking for or would like a center closer to home that may also provide similar clinical trials, refer to the Victorian Cancer Trials Link or Australian Clinical Trials Registry.